Bennett J, Das JM, Emmady PD. Spinal cord injuries. StatPearls Treasure Island, Florida: StatPearls Publishing; 2022. PMID: 32809556

Altems, Valutazione HTA del dispositivo medico Peristeen Plus®. https://altems.unicatt.it/altems-research-consultancy-valutazione-hta-del-dispositivo-medico-peristeen-plus. Accessed June 2024.

Emmanuel A, Kumar G, Christensen P, et al. Long-term cost-effectiveness of transanal irrigation in patients with neurogenic bowel dysfunction. PLoS One. 2016;11(8):e0159394. https://doi.org/10.1371/journal.pone.0159394 PMID:27557052

Emmanuel A, Kurze I, Krogh K, et al. An open prospective study on the efficacy of Navina Smart, an electronic system for transanal irrigation, in neurogenic bowel dysfunction. PLoS One. 2021;16(1):e0245453. https://doi.org/10.1371/journal.pone.0245453 PMID:33513187

Dale M, Morgan H, Carter K, White J, Carolan-Rees G. Peristeen transanal irrigation system to manage bowel dysfunction: a NICE medical technology guidance. Appl Health Econ Health Policy. 2019;17(1):25-34. https://doi.org/10.1007/s40258-018-0447-x PMID:30426450

Knowles CH, Booth L, Brown SR, et al. Non-drug therapies for the management of chronic constipation in adults: the CapaCiTY research programme including three RCTs. Programme Grants for Applied Research. 2021;9(14):1-134. https://doi.org/10.3310/pgfar09140 PMID:34855315

Musco S, Bazzocchi G, Martellucci J, et al. Treatments in neurogenic bowel dysfunctions: evidence reviews and clinical recommendations in adults. Eur J Phys Rehabil Med. 2020;56(6):741-755. PMID:32935955

Sengoku A, Noto S, Nomi M, Emmanuel A, Murata T, Mimura T. Cost-effectiveness analysis of transanal irrigation for managing neurogenic bowel dysfunction in Japan. J Health Econ Outcomes Res. 2018;6(1):37-52. https://doi.org/10.36469/9781 PMID:32685570

Sakakibara R. Gastrointestinal dysfunction in movement disorders. Neurol Sci. 2021;42(4):1355-1365. https://doi.org/10.1007/s10072-021-05041-4 PMID:33538914

Hultling C. Neurogenic bowel management using transanal irrigation by persons with spinal cord injury. Phys Med Rehabil Clin N Am. 2020;31(3):305-318. https://doi.org/10.1016/j.pmr.2020.04.003 PMID:32624096

Emmanuel AV, Krogh K, Bazzocchi G, et al; Members of working group on Trans Anal Irrigation from UK, Denmark, Italy, Germany, France and Netherlands. Consensus review of best practice of transanal irrigation in adults. Spinal Cord. 2013;51(10):732-738. https://doi.org/10.1038/sc.2013.86 PMID:23958927

National Institute for Health and Care Excellence (NICE). NICE Guidance. Peristeen transanal irrigation system for managing bowel dysfunction. Feb. 23, 2018. https://www.nice.org.uk/guidance/mtg36. (Accessed June 2024).

Juul T, Christensen P. Prospective evaluation of transanal irrigation for fecal incontinence and constipation. Tech Coloproctol. 2017;21(5):363-371. https://doi.org/10.1007/s10151-017-1635-7 PMID:28550422

Wellspect Italia. Navina Medical Internal Documents. Wellspect Italia; 2024.

Christensen P, Andreasen J, Ehlers L. Cost-effectiveness of transanal irrigation versus conservative bowel management for spinal cord injury patients. Spinal Cord. 2009;47(2):138-143. https://doi.org/10.1038/sc.2008.98 PMID:18679401

Emmanuel A, Collins B, Henderson M, Lewis L, Stackhouse K. Development of a decision guide for transanal irrigation in bowel disorders. Gastrointest Nurs. 2019;17(7):24-30. https://doi.org/10.12968/gasn.2019.17.7.24

Bardsley A. Transanal irrigation systems for managing bowel dysfunction: a review. Gastrointest Nurs. 2020;18(5):18-28. https://doi.org/10.12968/gasn.2020.18.5.18

Crawshaw A, Marshall J, Bartolo DC, et al. Evaluating gravity versus pump irrigation for bowel dysfunction. Gastrointest Nurs. 2009;7(7):34-42. https://doi.org/10.12968/gasn.2009.7.7.44267

Association of the British Pharmaceutical Industry (ABPI). Our industry: facts, figures and industry data. https://www.abpi.org.uk/facts-figures-and-industry-data/. (Accessed June 2024).

Ministero della Salute. Gazzetta Ufficiale. Prestazioni Di Assistenza Specialistica Ambulatoriale – Allegato 3. Jan. 28, 2013. https://www.gazzettaufficiale.it/atto/serie_generale/caricaArticolo?art.progressivo=0&art.idArticolo=1&art.versione=1&art.codiceRedazionale=13A00528&art.dataPubblicazioneGazzetta=2013-01-28&art.idGruppo=0&art.idSottoArticolo1=10&art.idSottoArticolo=1&art.flagTipoArticolo=3 (Accessed June 2024)

Ministero della Salute. Gazzetta Ufficiale. Tariffe Delle Prestazioni Di Assistenza Ospedaliera Per Acuti, Per Tipo Di Ricovero – Allegato 1. Jan. 28, 2013. https://www.gazzettaufficiale.it/atto/serie_generale/caricaArticolo?art.progressivo=0&art.idArticolo=1&art.versione=1&art.codiceRedazionale=13A00528&art.dataPubblicazioneGazzetta=2013-01-28&art.idGruppo=0&art.idSottoArticolo1=10&art.idSottoArticolo=1&art.flagTipoArticolo=1. (Accessed June 2024)

UK Drug Database. UK Drug Information. https://www.drugs.com/uk/. (Accessed June 2024).

Analytic Health. Data-driven actionable insights. https://analytichealth.co.uk/pharmly-analytics/?gad_source=1&gclid=CjwKCAjwoJa2BhBPEiwA0l0ImNRj_Zmn4lLZR2Wf11K0lJqivzDeS_Zi0nAcbk6vo1xUnI2bIvvHlRoCiUoQAvD_BwE. (Accessed June 2024).

National Health System Business Service Authority (NHS BSA). NHS Prescription Services, Drug Tariff. https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff. (Accessed June 2024).

Fattore G. A proposal for guidelines for the economic evaluation of health interventions in Italy. PharmacoEcon Ital Res Artic. 2009;11(2):83-93. https://doi.org/10.1007/BF03320660

Ruggeri M, Signorini A, Caravaggio S, et al. Estimation model for healthcare costs and intensive care units access for Covid-19 patients and evaluation of the effects of remdesivir in the Portuguese context: hypothetical study. Clin Drug Investig. 2022;42(4):345-354. https://doi.org/10.1007/s40261-022-01128-8 PMID:35298832

Ruggeri M, Signorini A, Caravaggio S, et al. Modeling the potential impact of remdesivir treatment for hospitalized patients with COVID-19 in Saudi Arabia on healthcare resource use and direct hospital costs: a hypothetical study. Clin Drug Investig. 2022;42(8):669-678. https://doi.org/10.1007/s40261-022-01177-z PMID:35838880

Ruggeri M, Signorini A, Drago C, Rosiello F, Marchetti M. Model for estimating the healthcare costs and capacity of intensive care units in Italy in the treatment of patients with COVID-19: remdesivir impact assessment. AboutOpen. 2020;7(1):95-102. https://doi.org/10.33393/abtpn.2020.2213

Rechel B. Funding for public health in Europe in decline? Health Policy. 2019;123(1):21-26. https://doi.org/10.1016/j.healthpol.2018.11.014 PMID:30509874